Mr. Gan · haixiao@sungolytest.com · +86 158 2169 5110 · +86 132 4819 8029Mr. Luo · jun.luo@sungoglobal.com · +86 177 5560 4650

QMZ

Digital Therapy Device To Reduce Sleep Disturbance For Psychiatric Conditions

Product code
QMZ
Device name
Digital Therapy Device To Reduce Sleep Disturbance For Psychiatric Conditions
Device class
Class 2
21 CFR
21 CFR 882.5705
Medical specialty
Neurology
Marketing pathway
510(K)
510(k) clearances (all years, FDA)
1 (all years; only the last 3 years are listed here)

FDA classification definition

A digital therapy device to reduce sleep disturbance for psychiatric conditions is a prescription device that is intended to provide stimulation using a general purpose computing platform to reduce sleep disturbance in patients who experience this symptom due to psychiatric conditions such as nightmare disorder or post traumatic stress disorder (PTSD).

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: QMZ
Classification and pathway per current FDA publications. Data from openFDA (CC0).